{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:44:44Z","timestamp":1790675084624,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,12,14]],"date-time":"2012-12-14T00:00:00Z","timestamp":1355443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,12,14]],"date-time":"2012-12-14T00:00:00Z","timestamp":1355443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s00296-012-2587-x","type":"journal-article","created":{"date-parts":[[2012,12,13]],"date-time":"2012-12-13T05:49:04Z","timestamp":1355377744000},"page":"1495-1504","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Rituximab: rescue therapy in life-threatening complications or refractory autoimmune diseases: a single center experience"],"prefix":"10.1007","volume":"33","author":[{"given":"Yolanda","family":"Braun-Moscovici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonatan","family":"Butbul-Aviel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludmila","family":"Guralnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kochava","family":"Toledano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doron","family":"Markovits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Rozin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menahem A.","family":"Nahir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Balbir-Gurman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,14]]},"reference":[{"key":"2587_CR1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1365-2141.2009.07718.x","volume":"146","author":"V McDonald","year":"2009","unstructured":"McDonald V, Leandro M (2009) Rituximab in non-haematological disorders of adults and its mode of action. BJH 146:233\u2013246","journal-title":"BJH"},{"key":"2587_CR2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V83.2.435.435","volume":"83","author":"ME Reff","year":"1994","unstructured":"Reff ME, Carner K, Chambers KS, Chinn PC, Leonard JE, Raab R et al (1994) Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 83:435\u2013445","journal-title":"Blood"},{"key":"2587_CR3","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/j.1600-6143.2006.01288.x","volume":"6","author":"MD Pescovitz","year":"2006","unstructured":"Pescovitz MD (2006) Rituximab, an anti-CD20 monoclonal antibody: history and mechanism of action. Am J Transplant 6:859\u2013866","journal-title":"Am J Transplant"},{"issue":"3","key":"2587_CR4","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6","volume":"42","author":"L Guillevin","year":"1999","unstructured":"Guillevin L, Durand-Gasselin B, Cevallos R et al (1999) Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 42(3):421\u2013430","journal-title":"Arthritis Rheum"},{"issue":"4","key":"2587_CR5","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/00005792-200007000-00003","volume":"79","author":"D Lauque","year":"2000","unstructured":"Lauque D, Cadranel J, Lazor R et al (2000) Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Groupe d\u2019Etudes et de Recherche sur les Maladies \u201cOrphelines\u201d Pulmonaires (GERM\u201cO\u201dP). Medicine (Baltimore) 79(4):222\u2013233","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"2587_CR6","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1136\/thorax.55.6.502","volume":"55","author":"MI Schwarz","year":"2000","unstructured":"Schwarz MI, Brown KK (2000) Small vessel vasculitis of the lung. Thorax 55(6):502\u2013510","journal-title":"Thorax"},{"issue":"5","key":"2587_CR7","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1378\/chest.08-2084","volume":"137","author":"AR Lara","year":"2010","unstructured":"Lara AR, Schwarz MI (2010) Diffuse alveolar hemorrhage. Chest 137(5):1164\u20131171","journal-title":"Chest"},{"issue":"6","key":"2587_CR8","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1177\/0961203310386276","volume":"20","author":"V Pottier","year":"2011","unstructured":"Pottier V, Pierrot M, Subra JF, Mercat A, Kouatchet A, Parrot A, Augusto JF. Successful rituximab therapy in a lupus patient with diffuse alveolar haemorrhage. Lupus. 2011 May; 20(6):656\u2013659. Epub 2011 Feb 18","journal-title":"Lupus"},{"issue":"2","key":"2587_CR9","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1093\/rheumatology\/kep356","volume":"49","author":"CB Narshi","year":"2010","unstructured":"Narshi CB, Haider S, Ford CM, Isenberg DA, Giles IP (2010) Rituximab as early therapy for pulmonary haemorrhage in systemic lupus erythematosus. Rheumatology (Oxford) 49(2):392\u2013394","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"2587_CR10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000156965","volume":"78","author":"LF Pinto","year":"2009","unstructured":"Pinto LF, Candia L, Garcia P, Mar\u00edn JI, Pach\u00f3n I, Espinoza LR, Marquez J (2009) Effective treatment of refractory pulmonary hemorrhage with monoclonal anti-CD20 antibody (rituximab). Respiration 78(1):106\u2013109","journal-title":"Respiration"},{"issue":"1","key":"2587_CR11","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/ndt\/gfm701","volume":"23","author":"CM Nellessen","year":"2008","unstructured":"Nellessen CM, P\u00f6ge U, Brensing KA, Sauerbruch T, Klehr HU, Rabe C (2008) Diffuse alveolar haemorrhage in a systemic lupus erythematosus patient successfully treated with rituximab: a case report. Nephrol Dial Transplant 23(1):385\u2013386","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"2587_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.semarthrit.2010.11.001","volume":"41","author":"U Arad","year":"2011","unstructured":"Arad U, Balbir-Gurman A, Doenyas-Barak K, Amit-Vazina M, Caspi D, Elkayam O (2011) Anti-neutrophil antibody associated vasculitis in systemic sclerosis. Semin Arthritis Rheum 41(2):223\u2013229","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"2587_CR13","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1177\/0961203311422713","volume":"21","author":"AS Elazary","year":"2012","unstructured":"Elazary AS, Klahr P, Hershko A, Dranitzki Z, Rubinow A, Naparstek Y (2012) Rituximab induces resolution of recurrent diffuse alveolar hemorrhage in a patient with primary antiphospholipid antibody syndrome. Lupus 21(4):438\u2013440","journal-title":"Lupus"},{"key":"2587_CR14","first-page":"355","volume":"33","author":"E Rubenstein","year":"2006","unstructured":"Rubenstein E, Arkfeld DG, Metyas S, Shinada S, Ehresmann S, Liebman HA (2006) Rituximab treatment for resistant antiphospholipid syndrome. J Rheumatol 33:355\u2013357","journal-title":"J Rheumatol"},{"key":"2587_CR15","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/MAJ.0b013e31815203ad","volume":"335","author":"H Manner","year":"2008","unstructured":"Manner H, Jung B, Tonassi L et al (2008) Successful treatment of catastrophic antiphospholipid antibody syndrome (CAPS) associated with splenic marginal-zone lymphoma with low-molecular weight heparin, rituximab and bendamustine. Am J Med Sci 335:394\u2013397","journal-title":"Am J Med Sci"},{"key":"2587_CR16","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1177\/0961203307087406","volume":"17","author":"S van Wissen","year":"2008","unstructured":"van Wissen S, Bastiaansen BMJ, Stroobants AK et al (2008) Catastrophic antiphospholipid syndrome mimicking a malignant pancreatic tumour\u2014a case report. Lupus 17:586\u2013590","journal-title":"Lupus"},{"key":"2587_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.semarthrit.2007.08.001","volume":"37","author":"RA Asherson","year":"2008","unstructured":"Asherson RA, Espinosa G, Menahem S et al (2008) Relapsing catastrophic antiphospholipid syndrome: report of three cases. Semin Arthritis Rheum 37:377\u2013382","journal-title":"Semin Arthritis Rheum"},{"key":"2587_CR18","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/pbc.21878","volume":"52","author":"AA Nageswara Rao","year":"2009","unstructured":"Nageswara Rao AA, Arteaga GM, Reed AM, Gloor JM, Rodriguez V (2009) Rituximab for successful management of probable pediatric catastrophic antiphospholipid syndrome. Pediatr Blood Cancer 52:536\u2013538","journal-title":"Pediatr Blood Cancer"},{"key":"2587_CR19","first-page":"699","volume":"87","author":"SK Jamoussi","year":"2009","unstructured":"Jamoussi SK, Zaghdoudi I, Ben Dhaou B et al (2009) Catastrophic antiphospholipid syndrome and rituximab: a new report. Tunis Med 87:699\u2013702","journal-title":"Tunis Med"},{"key":"2587_CR20","doi-asserted-by":"publisher","first-page":"e1523","DOI":"10.1542\/peds.2009-2939","volume":"125","author":"E Iglesias-Jim\u00e9nez","year":"2010","unstructured":"Iglesias-Jim\u00e9nez E, Camacho-Lovillo M, Falc\u00f3n-Neyra D, Lirola-Cruz J, Neth O (2010) Infant with probable catastrophic antiphospholipid syndrome successfully managed with rituximab. Pediatrics 125:e1523\u2013e1528","journal-title":"Pediatrics"},{"issue":"11","key":"2587_CR21","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.autrev.2011.04.031","volume":"10","author":"G Espinosa","year":"2011","unstructured":"Espinosa G, Berman H, Cervera R (2011) Management of refractory cases of catastrophic antiphospholipid syndrome. Autoimmun Rev 10(11):664\u2013668","journal-title":"Autoimmun Rev"},{"issue":"8","key":"2587_CR22","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1177\/0961203307087610","volume":"17","author":"S Hennigan","year":"2008","unstructured":"Hennigan S, Channick RN, Silverman GJ (2008) Rituximab treatment of pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report. Lupus 17(8):754\u2013756","journal-title":"Lupus"},{"issue":"4","key":"2587_CR23","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/j.1756-185X.2009.01438.x","volume":"12","author":"NL Lui","year":"2009","unstructured":"Lui NL, Thumboo J, Fong KY (2009) A case of refractory vasculitic ulcers in a systemic lupus erythematosus patient responding to rituximab and hyperbaric oxygen therapy. Int J Rheum Dis 12(4):366\u2013369","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"2587_CR24","first-page":"468","volume":"28","author":"M Ramos-Casals","year":"2010","unstructured":"Ramos-Casals M, Garc\u00eda-Hern\u00e1ndez FJ, de Ram\u00f3n E, Callejas JL, Mart\u00ednez-Berriotxoa A, Pallar\u00e9s L, Caminal-Montero L, Selva-O\u2019Callaghan A, Oristrell J, Hidalgo C, P\u00e9rez-Alvarez R, Mic\u00f3 ML, Medrano F, G\u00f3mez de la Torre R, D\u00edaz-Lagares C, Camps M, Ortego N, S\u00e1nchez-Rom\u00e1n J, BIOGEAS Study Group (2010) Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases. Clin Exp Rheumatol 28(4):468\u2013476","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"2587_CR25","first-page":"752","volume":"29","author":"R De Stefano","year":"2011","unstructured":"De Stefano R, Frati E, Nargi F, Menza L (2011) Efficacy of rituximab on pulmonary nodulosis occurring or increasing in patients with rheumatoid arthritis during anti-TNF- \u03b1 therapy. Clin Exp Rheumatol 29(4):752\u2013753","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"2587_CR26","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1111\/j.1445-5994.2011.02701.x","volume":"42","author":"N Child","year":"2012","unstructured":"Child N, O\u2019Carroll M, Berkahn L (2012) Rituximab-induced interstitial lung disease in a patient with immune thrombocytopenia purpura. Intern Med J 42(3):e12\u2013e14","journal-title":"Intern Med J"},{"issue":"4","key":"2587_CR27","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/rheumatology\/ker290","volume":"51","author":"AV Hadjinicolaou","year":"2012","unstructured":"Hadjinicolaou AV, Nisar MK, Parfrey H, Chilvers ER, Ost\u00f6r AJ (2012) Non-infectious pulmonary toxicity of rituximab: a systematic review. Rheumatology (Oxford) 51(4):653\u2013662","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"2587_CR28","doi-asserted-by":"publisher","first-page":"R131","DOI":"10.1186\/ar2798","volume":"11","author":"M Nakou","year":"2009","unstructured":"Nakou M, Katsikas G, Sidiropoulos P, Bertsias G, Papadimitraki E, Raptopoulou A, Koutala H, Papadaki HA, Kritikos H, Boumpas DT (2009) Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response. Arthritis Res Ther 11(4):R131","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"2587_CR29","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/art.22400","volume":"56","author":"K Vos","year":"2007","unstructured":"Vos K, Thurlings RM, Wijbrandts CA, van Schaardenburg D, Gerlag DM, Tak PP (2007) Early effects of rituximab on the synovial cell infiltrate in patients with rheumatoid arthritis. Arthritis Rheumatism 56(3):772\u2013778","journal-title":"Arthritis Rheumatism"},{"key":"2587_CR30","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1002\/art.23902","volume":"58","author":"S Dass","year":"2008","unstructured":"Dass S, Rawstron AC, Vital EM, Henshaw K, McGonagle D, Emery P (2008) Highly sensitive B cell analysis predicts response to rituximab therapy in rheumatoid arthritis. Arthritis Rheum 58:2993\u20132999","journal-title":"Arthritis Rheum"},{"issue":"3","key":"2587_CR31","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/art.30152","volume":"63","author":"EM Vital","year":"2011","unstructured":"Vital EM, Rawstron AC, Dass S, Henshaw K, Madden J, Emery P, McGonagle D (2011) Reduced-dose rituximab in rheumatoid arthritis: efficacy depends on degree of B cell depletion. Arthritis Rheum 63(3):603\u2013608","journal-title":"Arthritis Rheum"},{"key":"2587_CR32","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.1002\/art.22211","volume":"54","author":"G Cambridge","year":"2006","unstructured":"Cambridge G, Leandro MJ, Teodorescu M et al (2006) B cell depletion therapy in systemic lupus erythematosus: effect on autoantibody and antimicrobial antibody profiles. Arthritis Rheum 54:3612\u20133622","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2587-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-012-2587-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2587-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2587-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T16:36:49Z","timestamp":1659112609000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-012-2587-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,14]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["2587"],"URL":"https:\/\/doi.org\/10.1007\/s00296-012-2587-x","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,14]]},"assertion":[{"value":"19 June 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}